These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23933249)

  • 1. Superficial granulomatous pyoderma. Report of 2 cases treated with topical tacrolimus.
    Ormaechea-Pérez N; López-Pestaña A; Lobo-Morán C; Tuneu-Valls A
    Actas Dermosifiliogr; 2013 Oct; 104(8):721-4. PubMed ID: 23933249
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids.
    Doren EL; Aya-ay ML
    Aesthet Surg J; 2014 Mar; 34(3):394-9. PubMed ID: 24448967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pustular penile pyoderma gangrenosum successfully treated with topical tacrolimus ointment.
    Larsen CG; Thyssen JP
    Acta Derm Venereol; 2012 Jan; 92(1):104-5. PubMed ID: 21681352
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyoderma gangrensum--a complication of breast biopsy.
    Swinson BD; Morrison CM; Sinclair JS
    Ulster Med J; 2002 May; 71(1):66-7. PubMed ID: 12137170
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic absorption of topical tacrolimus in Pyoderma gangrenosum.
    Pitarch G; Torrijos A; Mahiques L; Sánchez-Carazo JL; Fortea JM
    Acta Derm Venereol; 2006; 86(1):64-5. PubMed ID: 16585995
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical tacrolimus therapy for pyoderma gangrenosum.
    Chiba T; Isomura I; Suzuki A; Morita A
    J Dermatol; 2005 Mar; 32(3):199-203. PubMed ID: 15863867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.
    Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G
    Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine.
    D'Incà R; Fagiuoli S; Sturniolo GC
    Ann Intern Med; 1998 May; 128(9):783-4. PubMed ID: 9556483
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of vulvar pyoderma gangrenosum associated with collagenous colitis.
    Roé E; Dalmau J; García-Navarro X; Corella F; Monfort D; Busquets D; Ribé A; Delgado E; Alomar A
    Dermatology; 2006; 213(3):234-5. PubMed ID: 17033174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is topical monotherapy effective for localized pyoderma gangrenosum?
    Le Cleach L; Moguelet P; Perrin P; Chosidow O
    Arch Dermatol; 2011 Jan; 147(1):101-3. PubMed ID: 21242400
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.
    Ciurea AM; Guitart J; Brieva J
    Arch Dermatol; 2010 Jan; 146(1):102-3. PubMed ID: 20083712
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum.
    Marzano AV; Trevisan V; Lazzari R; Crosti C
    J Dermatolog Treat; 2010 May; 21(3):140-3. PubMed ID: 19903010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tacrolimus for pyoderma gangrenosum.
    Reich K; Vente C; Neumann C
    Br J Dermatol; 1998 Oct; 139(4):755-7. PubMed ID: 9892935
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum.
    Weichert G; Sauder DN
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):648-50. PubMed ID: 9777778
    [No Abstract]   [Full Text] [Related]  

  • 17. Recalcitrant cases of pyoderma gangrenosum, responding dramatically to systemic tacrolimus.
    Sadati MS; Dastgheib L; Aflaki E
    G Ital Dermatol Venereol; 2017 Jun; 152(3):308-310. PubMed ID: 28409579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum.
    Richter-Hintz D; Schuppe HC; Homey B; Lehmann P; Ruzicka T
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):304-5. PubMed ID: 10642695
    [No Abstract]   [Full Text] [Related]  

  • 19. [An unusual case of pyoderma gangrenosum with necrotizing granulomatous dermatitis].
    Meier F; Berner D; Scherwitz C; Rassner G; Metzler G
    J Dtsch Dermatol Ges; 2003 Apr; 1(4):302-5. PubMed ID: 16285486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case Series of 4 Patients With Peristomal Pyoderma Gangrenosum: Review of Risk Factors and Treatment Response.
    Turrión-Merino L; Hermosa-Zarza E; Miguel L; Muñoz-Zato E
    Actas Dermosifiliogr; 2016 Apr; 107(3):e13-7. PubMed ID: 26626501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.